Based on an analysis of data, FDA has concerns about whether or not two approved
generic versions of
Concerta tablets (methylphenidate hydrochloride extended-release tablets), used to treat attention-deficit hyperactivity disorder in adults and children, are therapeutically equivalent to the brand-name drug.Nov 7, 2016
read more >>